UCSF

Topics and Expertise: recombinant antibodies

Wells named a fellow of National Academy of Inventors

James Wells, PhD, whose pioneering innovations in protein engineering and technologies to identify small molecules to aid in drug discovery have yielded more than 60 patents, launched three companies, and created two UCSF technology centers, has been elected as a fellow to the National Academy of...

Antibody Network partners with Celgene to develop cancer therapies

A new collaboration between Celgene Corp. and the Recombinant Antibody Network (RAN) will support the development of next-generation, antibody-based cancer therapies.